PFCS
AQST icon

Pale Fire Capital SE’s Aquestive Therapeutics AQST Stock Holding History

Pale Fire Capital SE’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-93,132
Closed -$521K – 63
2025
Q3 		$521K Sell
93,132
-1,583,319
-94% -$6.85M 0.06% 35
2025
Q2 		$5.55M Buy
1,676,451
+340,767
+26% +$977K 0.57% 23
2025
Q1 		$3.87M Buy
1,335,684
+809,928
+154% +$2.45M 0.46% 19
2024
Q4 		$1.87M Buy
525,756
+501,756
+2,091% +$2.31M 0.42% 15
2024
Q3 		$120K Buy
+24,000
New +$93.4K 0.02% 44

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pale Fire Capital SE's AQST Position: Q4 2025 in Review

Pale Fire Capital SE sold out of Aquestive Therapeutics (AQST) in Q4 2025, closing a stake of 93,132 shares — an estimated $521K sold.

Pale Fire Capital SE first reported a position in AQST in Q3 2024 and held it in 5 quarters. The position peaked at $5.55M in Q2 2025. 176 funds tracked by Wall St. Rank hold AQST as of Q4 2025.

  • Pale Fire Capital SE reported no remaining Aquestive Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Pale Fire Capital SE sold 93,132 Aquestive Therapeutics shares in Q4 2025, an estimated $521K.
  • Pale Fire Capital SE first reported a position in Aquestive Therapeutics in Q3 2024 and held it in 5 quarters.
  • Pale Fire Capital SE's Aquestive Therapeutics position peaked at $5.55M in Q2 2025.
  • 176 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2025.

Based on Pale Fire Capital SE's 13F filing for Q4 2025, filed 13 Feb 2026.